JNJ

238.23

-0.2%↓

UNH

273.19

-0.82%↓

TMO

539.43

-1.35%↓

ABT

112.32

+1.08%↑

ISRG

495.1

+0.46%↑

JNJ

238.23

-0.2%↓

UNH

273.19

-0.82%↓

TMO

539.43

-1.35%↓

ABT

112.32

+1.08%↑

ISRG

495.1

+0.46%↑

JNJ

238.23

-0.2%↓

UNH

273.19

-0.82%↓

TMO

539.43

-1.35%↓

ABT

112.32

+1.08%↑

ISRG

495.1

+0.46%↑

JNJ

238.23

-0.2%↓

UNH

273.19

-0.82%↓

TMO

539.43

-1.35%↓

ABT

112.32

+1.08%↑

ISRG

495.1

+0.46%↑

JNJ

238.23

-0.2%↓

UNH

273.19

-0.82%↓

TMO

539.43

-1.35%↓

ABT

112.32

+1.08%↑

ISRG

495.1

+0.46%↑

Search

McKesson Corp

Geschlossen

BrancheGesundheitswesen

934.03 -2.79

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

929.13

Max

961.85

Schlüsselkennzahlen

By Trading Economics

Einkommen

40M

1.3B

Verkäufe

3B

106B

KGV

Branchendurchschnitt

27.781

84.243

Dividendenrendite

0.32

Gewinnspanne

1.177

Angestellte

43,000

EBITDA

374M

1.8B

Empfehlungen

By TipRanks

Empfehlungen

Starkes Kaufsignal

12-Monats-Prognose

-0.16% downside

Dividenden

By Dow Jones

Dividendenrendite

Branchendurchschnitt

0.32%

2.28%

Nächstes Ergebnis

7. Mai 2026

Nächste Dividendenausschüttung

1. Apr. 2026

Nächstes Ex-Dividendendatum

2. März 2026

Marktstatistiken

By TradingEconomics

Marktkapitalisierung

13B

119B

Vorheriger Eröffnungskurs

936.82

Vorheriger Schlusskurs

934.03

Nachrichtenstimmung

By Acuity

33%

67%

86 / 352 Ranking in Healthcare

Technischer Score

By Trading Central

Vertrauen

Strong Bearish Evidence

McKesson Corp Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

10. Feb. 2026, 23:26 UTC

Wichtige Markttreiber

Moderna Stock Slips After FDA Refuses Flu Vaccine Review

10. Feb. 2026, 22:31 UTC

Ergebnisse

Correction to America Movil 4Q Profit Article

10. Feb. 2026, 22:22 UTC

Ergebnisse

America Movil 4Q Profit Jumps on Lower Financial Costs

10. Feb. 2026, 23:51 UTC

Market Talk
Ergebnisse

Commonwealth Bank's Margin Management Gives It a Platform -- Market Talk

10. Feb. 2026, 23:42 UTC

Market Talk

Gold Rises Amid Fed Rate-Cut Prospects -- Market Talk

10. Feb. 2026, 23:40 UTC

Market Talk
Ergebnisse

Commonwealth Bank Bear Says 1H Result Looks Strong -- Market Talk

10. Feb. 2026, 23:21 UTC

Market Talk

Ford Says EV Shift Was Driven by Demand Changes -- Market Talk

10. Feb. 2026, 23:21 UTC

Market Talk

Global Equities Roundup: Market Talk

10. Feb. 2026, 22:17 UTC

Market Talk

Australia's One Nation Now Commands Working Class Vote -- Market Talk

10. Feb. 2026, 22:15 UTC

Ergebnisse

Humana Earnings Will Shed More Light on Medicare Prospects -- Barrons.com

10. Feb. 2026, 22:10 UTC

Ergebnisse

Intact Financial 4Q Book Value Per Share Was C$107.35 >IFC.T

10. Feb. 2026, 22:10 UTC

Ergebnisse

Intact Financial Raises Qtr Dividend to C$1.47 >IFC.T

10. Feb. 2026, 22:09 UTC

Ergebnisse

Intact Financial 4Q Combined Ratio Was 85.9% >IFC.T

10. Feb. 2026, 22:09 UTC

Ergebnisse

Intact Financial 4Q Adj EPS C$5.50 >IFC.T

10. Feb. 2026, 22:01 UTC

Ergebnisse

Intact Financial 4Q EPS C$5.24 >IFC.T

10. Feb. 2026, 21:54 UTC

Ergebnisse

James Hardie Industries Sees FY26 Total Adjusted EBITDA $1.232B to $1.263B >JHX

10. Feb. 2026, 21:53 UTC

Ergebnisse

Robinhood Stock Tumbles as Crypto-Related Revenue Falls Short of Expectations -- Barrons.com

10. Feb. 2026, 21:51 UTC

Ergebnisse

James Hardie Industries Sees FY26 Free Cash Flow at Least $200M

10. Feb. 2026, 21:51 UTC

Ergebnisse

Gilead Earnings Surprise. Why The Stock Is Tumbling Anyway. -- Barrons.com

10. Feb. 2026, 21:51 UTC

Ergebnisse

James Hardie Industries: Focused on the Achievement of $125 M Target >JHX

10. Feb. 2026, 21:51 UTC

Ergebnisse

James Hardie Industries: Integration and Cost Synergies Ahead of Schedule >JHX

10. Feb. 2026, 21:51 UTC

Ergebnisse
Akquisitionen, Fusionen, Übernahmen

Evolution Net Debt A$362 Million at Dec. 31 Vs A$1.29 Billion Year Earlier

10. Feb. 2026, 21:50 UTC

Ergebnisse
Akquisitionen, Fusionen, Übernahmen

Evolution: Gearing 6% at Dec. 31, From 23% a Year Earlier

10. Feb. 2026, 21:50 UTC

Ergebnisse

James Hardie Industries 3Q EPS 12c >JHX

10. Feb. 2026, 21:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

10. Feb. 2026, 21:50 UTC

Ergebnisse

James Hardie Industries 3Q Adj EPS 24c >JHX

10. Feb. 2026, 21:49 UTC

Ergebnisse

James Hardie Industries 3Q Sales $1.24B >JHX

10. Feb. 2026, 21:49 UTC

Ergebnisse
Akquisitionen, Fusionen, Übernahmen

Evolution 1H Operating Mine Cash Flow a Record A$1.73 Billion

10. Feb. 2026, 21:48 UTC

Ergebnisse
Akquisitionen, Fusionen, Übernahmen

Evolution 1H Ebitda A$1.56 Billion, Up 59% On-Year

10. Feb. 2026, 21:47 UTC

Ergebnisse
Akquisitionen, Fusionen, Übernahmen

Evolution 1H Revenue A$2.79 Billion, Up 37% On-Year

Peer-Vergleich

Kursveränderung

McKesson Corp Prognose

Kursziel

By TipRanks

-0.16% Nachteil

12-Monats-Prognose

Durchschnitt 960.8 USD  -0.16%

Hoch 1,012 USD

Tief 885 USD

Basierend auf 10 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für McKesson Corp – Dist angeboten haben.

Rating-Konsens

By TipRanks

Starkes Kaufsignal

10 ratings

8

Buy

2

Halten

0

Sell

Technischer Score

By Trading Central

681.92 / 707.28Unterstützung & Widerstand

Kurzfristig

Strong Bearish Evidence

Mittelfristig

No Evidence

Langfristig

No Evidence

Stimmung

By Acuity

86 / 352 Ranking in Gesundheitswesen

Nachrichtenstimmung

Bullische Evidenz

Volatilität

Unterdurchschnittlich

Nachrichtenvolumen (RCV)

Unterdurchschnittlich

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

Zinsaufwand für Schulden

EBITDA

Betriebsergebnis

$

Über McKesson Corp

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products. This segment also offers practice management, technology, clinical support, and business solutions to community-based oncology and other specialty practices; and consulting, outsourcing, technological, and other services, as well as sells financial, operational, and clinical solutions to pharmacies. The RxTS segment serves biopharma and life sciences partners, and patients to address medication challenges for patients by working across healthcare; connects patients, pharmacies, providers, pharmacy benefit managers, health plans, and biopharma companies to deliver innovative solutions to help people get the medicine needed to live healthier lives; and provides prescription price transparency, benefit insight, dispensing support, third-party logistics, and wholesale distribution support services. The Medical-Surgical Solutions segment offers medical-surgical supply distribution, logistics, and other services to healthcare providers, including physician offices, surgery centers, nursing homes, hospital reference labs, and home health care agencies. The International segment provides distribution and services to wholesale, institutional, and retail customers in Europe and Canada. McKesson Corporation was founded in 1833 and is headquartered in Irving, Texas.
help-icon Live chat